Pyschological Stress can induce Oxidative Stress-mediated Vascular Injury

Size: px
Start display at page:

Download "Pyschological Stress can induce Oxidative Stress-mediated Vascular Injury"

Transcription

1 Pyschological Stress can induce Oxidative Stress-mediated Vascular Injury Ick-Mo Chung, MD, PhD Cardiology Division Ewha Womans University

2 Contents Evidence of psychological stress as a risk factor for CAD Possible underlying mechanism by which psychological stress injure the vessel - Oxidative stress : ROCK, RGS - Inflammation

3 Allostatic Load Allostasis: ability to achieve stability through change Allostatic load: long term effect of physiological response to Stress McEwen BS. N Engl J Med 1998;338:171

4 Psychological stress as a risk factor for CVD Psychological stress is estimated as an emerging risk factor for atherosclerosis. - Stress: threatened homeostasis provoked by stressor. - Psychological factors contribute to the development and progression of CAD: depression, anxiety, personality and character traits, social isolation, and chronic life stress Physiological response to stress is mediated by the activation of sympathetic nervous system (SNS) and hypothalamic pituitary adrenal (HPA) axis. Stress can induce inflammation in peripheral organ through neuroendocrine system

5 Social stress and Atherosclerosis in normocholesterolemic monkeys Rate of aggressionφ Severe aggression % Rate of submission Severe submission % Time in affiliation % Stress (n=15) * * 21.0* Control (n=14) Intimal area (mm 2 ) Φ median rates of performance per hour per monkey, * p<0.05 Arteries with plaques 11/15 (stress) vs 4/14 (control) p< stress s control Kaplan JR. Science.1983;220:

6 Anger proneness predicts CHD risk Prospective analysis from the Atherosclerosis Risk In Communities (ARIC) Study Williams JE. Circulation. 2000;101: Aim 1. dose-response relation between anger and CHD risk 2. relation of CHD free survival with anger level Methods Prospective design (median 53 mo, 6yr Max. f/u) ARIC study (n=13,208) white and black men and women (45-64 yr) without CHD 10-item Spielberger Trait Anger Scale CHD events: acute MI/fatal CHD (hard event), silent MI, revascularization procedure

7 CHD event free survival probabilities by Trait Anger scores Normotensive Hypertensive P=NS P=.001 Williams JE. Circulation. 2000;101:

8 Intensive lifestyle changes for reversal of CHD Ornish D. JAMA. 1998;280: Lifestyle Heart Trial (JAMA1983;249:54-9) Comprehensive lifestyle changes (1 yr) without lipid lowering drug could reduce LDL-chol by 37% and reduce frequency of angina attack by 91% Aims Effect of sustained lifestyle changes on risk factors, coronary atherosclerosis, and cardiac events after 4 additional yr. Patients: angiography-proven CAD Pts Intensive Lifestyle Program 10% fat vegetarian diet, moderate aerobic exercise, stress management, smoking cessation, and group psychosocial support for 5 yrs avoid simple sugars, emphasize intake of complex carbohydrates and other whole foods

9 Angina symptoms Cardiac events during 5 yr f/u * * *

10 Mean percentage diameter stenosis P=.001 P=.02 Ornish, D. et al. JAMA 1998;280:

11 Reduction in the incidence of type II DM with lifestyle intervention or metformin Diabetes Prevention Program Research Group N Engl J Med 2002;346:393 Question Does a lifestyle intervention or Tx with metformin prevent or delay the onset of DM? Inclusion criteria BMI: 24, plasma glucose: (AC) mg/dl, PC mg/dl - Standard lifestyle with metforrmin 850 mg bid : food guide pyramid NCEP step 1 diet - Intensive lifestyle modification 16-session curriculum covering diet, exercise, and behavior modification, weight reduction >7% through a healthy low calorie, low fat diet, moderate physical activity s/a brisk walking 150 min /wk

12 Cumulative incidence of DM P<.001 Diabetes Prevention Program Research Group NEJM. 2002;346:

13 MDA final / MDA baseline e-nos mrna/ β actin mrna ** ** MDA * stress losartan ramipril control enos mrna * ** * * NOx final / NOx baseline Immobilization stress induces changes in ROS Plasma NOx ** ** ** * stress losartan ramipril control *p<0.05, **p<0.01, p<0.05 for final vs baseline M±SEM 0.0 stress losartan ramipril control Chung I-M & Kim YM Circ Res 2004;93:1523 (abstr)

14 Changes in Ach-induced arterial relaxation stress losartan ramipril control ** ** ** ** ** ** *p<0.05 **p<0.01 p=0.086 M±SEM Relaxation (%) * ** ** Concentration of Ach (log 10 M)

15 Immobilization stress can enhance expression of VCAM-1 VCAM-1 % VCAM-1 positive cells * *p<0.01 vs stress p=0.086 vs stress * <10% 10% VCAM-1 EC EC Stress SD AA 0 stress losartan ramipril control Control SD AA Bar: 50 μm

16 Effect of CUS on NF-κB activation induced by LPS or saline (SAL) in the frontal cortex (A), hypothalamus (B), or hippocampus (C) Munhoz, C. D. et al. J. Neurosci. 2006;26:

17 Plasma IL-6 and NF-κB DNA Binding in PBMC of Patients With Major Depression After a Psychosocial Stressor Challenge Miller AH, Am J Psychiatry 2006;163:1630

18 Neurogenic Inflammation in Stress Both somatic and autonomic nerves are associated with inflammatory cells, and nervous transmission may result in neurogenic inflammation : Nervous innervation is a requirement for establishing certain inflammatory reaction: eg. rhematoid arthritis Direct linkage between neurogenic stimulation and proinflammatory cytokine release - contributing inflammatory mediators in stress PGE2: + SN ending Neuropeptide Y: cotransmitter of SN innervation promotes SMC proliferation, enhances leukocyte adhesion, platelet aggregation, and MΦ activation CRF: + in SN ending, sensory N, spinal cord Substance P: + in autonomic N, ganglia, spinal cord, IL-6: + in sensory N, autonomic N

19 Vascular Injury mediated through Oxidative Stress Response to injury Hypothesis Injury to the endothelium might precipitate the atherosclerotic process (Virchow R, 1856) Atherosclerotic lesions result from an excessive inflammatoryfibroproliferative response various forms of insult to the endothelium and smooth muscle of the artery wall (Ross R,Nature. 1993) Oxidative stress, an excessive production of ROS outstripping antioxidant defense systems, has been implicated in many pathophysiological conditions in cardiovascular systems (atherosclerosis, hypertension, restenosis, smoking, hypercholesterolemia, DM, hypertension, heart failure), cancer, and neurodegeneration.

20 Vascular ROS 10 x Griendling KK et al. Circulation.2003;108:1912-6

21 Peroxynitrite (ONOO - ) strong oxidant: oxidative damage of DNA, RNA, proteins, lipids Mediator of protein nitration Promotes inflammatory synthesis of prostaglandin by activating cyclooxygenase (COX) Attack prostacyclin synthase (Tyr nitration?): Accumulating PGH 2 can activate thromboxane receptors, thereby promoting vasoconstriction Deactivate anti-inflammatory agents Activate c-jun-nh 2 -terminal kinase (JNK) thereby inducing a wide range of stress-related responses including apoptosis Protective role: microbicidal agent, limit bleeding Beckman JS, Circ Res 2001;89:295

22 Potential sources of ROS * rac1, AngII, TNF-α, thrombin, PDGF * Griendling KK et al. Circulation.2003;108:1912-6

23 Consequences of NAD(P)H oxidase activation Harrison DG, 2003;24:

24 Peroxynitrite can increase MMP2 activity Effect of ONOO - on gelatinolytic activity in human SMCs Effect of ONOO - on collagenolytic activity in human SMCs Gallis ZS, J Clin Invest 1996;98:2572 Fluorographic image of 3 H-type IV collagen

25 Regulation of myosin II in SMC and non-muscle cells AT1R IL-1β Somlyo AP. J Phys 2000;522:1777

26 Regulation of enos by ROCK Liao JK, Am J Physiol Cell Physiol 290: C661-C668, 2006

27 Ang II-mediated coronary vascular hypertrophy: role of Rho-kinase Shimokawa H. Circ Res 2003;93:767-75

28 Ang II-mediated vascular macrophage accumulation Role of Rho-kinase Shimokawa H. Circ Res 2003;93:767-75

29 Ang II-mediated NADPH oxidase: Role of Rho-kinase Shimokawa H. Circ Res 2003;93:767-75

30 ROCK inhibition improves endothelial function in CAD Nohria A. et al. Circ Res. 2006;99:1426

31 Active ROCK-α associates with Insulin Receptor Substrate-1 and inhibits insulin signaling in VSMCs Begum N, J Biol Chem 2002;277:6214

32

33 Ang II induce expression and activation of ROCK via NF-κB in vivo Shimokawa H, J Mol Cell Cardiol 2004;37:537

34 AbdAlla S et al. Cell 2004;119:343-54

35 Mononuclear phagocytes in atherogenesis Libby P. Nature 2002;420:868

36 G-Protein coupled Receptor (G-PCR) Signaling Model 23 known Gα protein Gα(s/olf) Gα(i1/i2/i3/t-rod/t-con/gust/z) Gα(q/11/14/16) Gα(12/13) AC GIRK, ERK1/2, JNK, PI3Kr, PLCβ/-ε MAPKs etc. McCudden CR. CMLS 2005;62:551

37 GPCR signaling & Cariovascular disease G αq transgenic overexpression mediates changes in heart function leading to hypertrophy (D Angello D. PNAS197;94:8121). RGS2+/- and RGS2-/- are hypertensive and show prolonged response of the vasculature to vasoconstrictor in vivo. (Heximer SP, J Clin Invest 2003) Transgenic overexpression of RGS4 in aortic coarctation mice model reduced ventricular hypertrophy and rapid decompensation (Rogers JH. J Clin Invest 1999)

38 Differential expression of RGS proteins in each vascular segments mrna fold change RGS1 RGS2 RGS3 RGS4 RGS8 RGS16 RGS5 * RGS5 mrna fold change p<0.05 vs TA of * RGS2 RGS3 RGS4 RGS5 RGS16 0 CCA TA AA CIA MA PA IVC 0 Chung I-M & Schwartz SM. AHA 2006

39 Decreased arterial contraction in abdominal vs thoracic aorta Force (mn) A TA, AA * * * Force (mn) B [Angiotensin II] (nm) [Phenylephrine] (µm)

40 AT1R-stimulated NFAT Activation in Cardiac Fibroblast Kurose H. J Biol Chem. 2005;280:

41 G12/13 mediate Ang II-induced ROS production Fujii, T. et al. J. Biol. Chem. 2005;280:

42 AT1 receptor Oxidative stress Monocytes attraction-mcp-1 Activation CD11b/18 expression Hematopoiesis Endothelial cells Endothelial dysfunction ICAM-1,VCAM-1 Apoptosis Growth factors Cytokines VSMC Contraction Migration Proliferation Apoptosis Cytokines growth factors Matrix metalloproteinase Lipids Oxidation oxldl-uptake Lox-1-expression Coagulation PAI-1 tpa Plaque formation Endothelial dysfunction Plaque rupture-thrombosis

43 Psychological Stress-mediated CV disease RAS, NE, Ach, etc SNS PVN_Hupothalamus CRH HPA Neuropeptides ex. Substance P? Locus Coeruleus NE Ant Pituitary gl POMC: ACTH,GH β-endorphin α-msh Neurogenic Inflammation? Adrenal medulla E & NE RAS ROCK Adrenal cortex corticosteroid Oxidative stress Endoth dysfunction Inflammation Insulin resistance CV remodeling & hypertrophy

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,

More information

Cardiovascular Protection and the RAS

Cardiovascular Protection and the RAS Cardiovascular Protection and the RAS Katalin Kauser, MD, PhD, DSc Senior Associate Director, Boehringer Ingelheim Pharmaceutical Inc. Micardis Product Pipeline Scientific Support Ridgefield, CT, USA Cardiovascular

More information

Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts

Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts Serena Del Turco, Teresa Navarra, Giuseppina Basta, Raffaele De

More information

PHM142 Lecture 4: Platelets + Endothelial Cells

PHM142 Lecture 4: Platelets + Endothelial Cells PHM142 Lecture 4: Platelets + Endothelial Cells 1 Hematopoiesis 2 Platelets Critical in clotting - activated by subendothelial matrix proteins (e.g. collagen, fibronectin, von Willebrand factor) and thrombin

More information

The Study of Endothelial Function in CKD and ESRD

The Study of Endothelial Function in CKD and ESRD The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:

More information

Biotherapy of Arteriosclerosis

Biotherapy of Arteriosclerosis Biotherapy of Arteriosclerosis Clinical Significance Non-pharmacological & Pharmacological intervention Pathogenesis related with Ang II-mediated oxidative stress Ick-Mo Chung, MD, PhD Division of Cardiology

More information

Novel Markers of Arterial Dysfunction

Novel Markers of Arterial Dysfunction 혈관연구회창립심포지움, 3 월 3 일, 2005 Novel Markers of Arterial Dysfunction Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon Medical School Incheon, Korea Atherosclerosis: A progressive process PHASE I: Initiation

More information

Classification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy

Classification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial

More information

The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction

The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction Cardiovascular Center, Korea University Guro Hospital 2007. 4. 20 Seung-Woon Rha, MD, PhD Introduction 1.

More information

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret

ROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

Novel function of NADPH oxidase in atherosclerosis. Yun Soo Bae Department of Life Science Ewha Womans University

Novel function of NADPH oxidase in atherosclerosis. Yun Soo Bae Department of Life Science Ewha Womans University Novel function of NADPH oxidase in atherosclerosis Yun Soo Bae Department of Life Science Ewha Womans University Recent understanding of ROS: act as second messengers e e Catalase/peroxidase O 2 H 2 O

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Endothelium. A typical endothelial cell is about 30mm long, Accounts for 1% or less of the arterial weight

Endothelium. A typical endothelial cell is about 30mm long, Accounts for 1% or less of the arterial weight Endothelium Discovered in 1845 A typical endothelial cell is about 30mm long, 10mm wide, and 0.2 3 mm thick Accounts for 1% or less of the arterial weight As recently as the late 1960s it was thought of

More information

Role of Alpha-lipoic acid(ala) and statin in vascular smooth muscle cell proliferation

Role of Alpha-lipoic acid(ala) and statin in vascular smooth muscle cell proliferation Role of Alpha-lipoic acid(ala) and statin in vascular smooth muscle cell proliferation In-kyu Lee, M.D., Ph. D. Dept. of Internal Med, Keimyung Univ., School of Med. Taegu, Korea Oxidative Stress and Atherosclerosis

More information

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System

More information

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Dyslipidemia Endothelial dysfunction Free radicals Immunologic ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and

More information

INFLAMMATION & REPAIR

INFLAMMATION & REPAIR INFLAMMATION & REPAIR Lecture 7 Chemical Mediators of Inflammation Winter 2013 Chelsea Martin Special thanks to Drs. Hanna and Forzan Course Outline i. Inflammation: Introduction and generalities (lecture

More information

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories Cardiac biomarkers in atherosclerosis Najma Asadi MD-APCP Ross and Colleagues in 1973: Response to Injury

More information

Macrovascular Disease in Diabetes

Macrovascular Disease in Diabetes Macrovascular Disease in Diabetes William R. Hiatt, MD Professor of Medicine/Cardiology University of Colorado School of Medicine President, CPC Clinical Research Conflicts CPC Clinical Research (University-based

More information

NAM JUNE PAIK: Rhapsody in Video

NAM JUNE PAIK: Rhapsody in Video NAM JUNE PAIK: Rhapsody in Video 혈관연구회추계학회 2007.10.13 Renin-angiotensin-aldosterone System Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon University Gil Medical Center Incheon, Korea Cytokines oxldl Ang

More information

LXIV: DRUGS: 4. RAS BLOCKADE

LXIV: DRUGS: 4. RAS BLOCKADE LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations

More information

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular

More information

Endothelial Injury and Repair as a Working Paradigm

Endothelial Injury and Repair as a Working Paradigm Endothelial Injury and Repair as a Working Paradigm A. Linke ESC Meeting 2010 UNIVERSITÄTLEIPZIG H ERZZEN TRUM Physiology of Endothelial Function: Regulation of Vascular Tone L-Arg. L-Arg. Agonists Shear

More information

Child born in year /3 will die before parents in US (diabetes)

Child born in year /3 will die before parents in US (diabetes) Child born in year 2000-1/3 will die before parents in US (diabetes) ATP III identified 6 components of the metabolic syndrome that relate to CVD 1. Abdominal obesity 2. Atherogenic dyslipidemia (elevated

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

and Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine

and Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine PPAR- Agonist and In-Stent Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine Peroxisome Proliferator- activated Receptors (PPAR) Lipid-activated transcription factors : => regulating

More information

Depression in Peripheral Artery Disease: An important Predictor of Outcome. Goals. Goals. Marlene Grenon, MD Assistant Professor of Surgery, UCSF

Depression in Peripheral Artery Disease: An important Predictor of Outcome. Goals. Goals. Marlene Grenon, MD Assistant Professor of Surgery, UCSF Depression in Peripheral Artery Disease: An important Predictor of Outcome There are no conflicts of interest Marlene Grenon, MD Assistant Professor of Surgery, UCSF UCSF VASCULAR SURGERY SYMPOSIUM SAN

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

VALUE OF ACEI IN THE MANAGEMENT OF HYPERTENSION

VALUE OF ACEI IN THE MANAGEMENT OF HYPERTENSION VALUE OF ACEI IN THE MANAGEMENT OF HYPERTENSION Dr Catherine BESEME Paris 6 th December 2005 6 th International Congress of Bangladesh Society of Medicine Hypertension is a risk factor at the source, with

More information

Metabolic Syndrome. DOPE amines COGS 163

Metabolic Syndrome. DOPE amines COGS 163 Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance

More information

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1

More information

Inflammation: Novel Target for Cardiovascular Risk Reduction

Inflammation: Novel Target for Cardiovascular Risk Reduction Inflammation: Novel Target for Cardiovascular Risk Reduction Andrew Zalewski, M.D. Thomas Jefferson University, Philadelphia GlaxoSmithKline, Philadelphia Why inflammation? Population-based studies: low

More information

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Atherosclerosis, 2007 Chiba T, Shinozaki S, Nakazawa T, et al. Present by Sudaporn Pummoung Apolipoprotein E (apoe( apoe)

More information

Cardiovascular System and Health. Chapter 15

Cardiovascular System and Health. Chapter 15 Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer

More information

Supplementary Figure 1:

Supplementary Figure 1: Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas

More information

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016

Cardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016 Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process

More information

Arteriosclerosis & Atherosclerosis

Arteriosclerosis & Atherosclerosis Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,

More information

Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?

Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown

More information

Estrogens vs Testosterone for cardiovascular health and longevity

Estrogens vs Testosterone for cardiovascular health and longevity Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in

More information

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Content Introduction The number 1 killer in America Some statistics

More information

Eicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different?

Eicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different? Eicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different? Trevor A Mori, Ph.D., Professor, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth,

More information

ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ

ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΘΩΜΑΣ ΠΑΠΑΔΟΠΟΥΛΟΣ, MD, PHD ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΙΑΤΡΙΚΟ ΔΙΑΒΑΛΚΑΝΙΚΟ ΚΕΝΤΡΟ Inflammation as a cause of disease has entered the popular imagination. Diet ( macronutrients )

More information

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida The 21 st Century Paradigm Shift: Prevention Rather Than Intervention for the Treatment of Stable CHD The Economic Burden of Cardiovascular Diseases Basil Margolis MD, FACC, FRCP Director, Preventive Cardiology

More information

Who Cares About the Past?

Who Cares About the Past? Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring

More information

Stress and Disease. Chapter 8. Elsevier items and derived items 2008 by Mosby, Inc., an affiliate of Elsevier Inc.

Stress and Disease. Chapter 8. Elsevier items and derived items 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Stress and Disease Chapter 8 Stress A person experiences stress when a demand exceeds a person s coping abilities, resulting in reactions such as disturbances of cognition, emotion, and behavior that can

More information

A real life example In human studies, we quantify ~120 plasma related proteins Monocytes MMP9 Macrophages TNFα IL1ß platelet derived growth factor IFNγ MMP1 MMP8 MMP13 Myeloid Related Protein14 CD40

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Can seal oil contribute to better human health?

Can seal oil contribute to better human health? Can seal oil contribute to better human health? Bjarne Østerud and Edel O. Elvevoll, Faculty of Medicine and NFH, University of Tromsø E-mail: bjarne@fagmed. Historical background Old food lore of seafood

More information

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

Platelet function in diabetes

Platelet function in diabetes Platelet function in diabetes Agneta Siegbahn, MD, PhD, FESC Professor Clinical Coagulation Science Department of Medical Sciences and Uppsala Clinical Research Center Uppsala University Disclosures: None

More information

Role of Inflammation in Pulmonary Hypertension

Role of Inflammation in Pulmonary Hypertension Role of Inflammation in Pulmonary Hypertension K. R. Stenmark University of Colorado Denver, USA Prominent Fibroproliferative Changes are Observed in the Lung Vasculature of Infants With Pulmonary Arterial

More information

Vulnerable Plaque. Atherothrombosis

Vulnerable Plaque. Atherothrombosis Vulnerable Plaque Nuove acquisizioni sull'aterosclerosi: placca vulnerabile Marina Camera Dip. Scienze Farmacologiche, Facoltà di Farmacia, Università degli Studi di Milano & Laboratorio di Biologia Cellulare

More information

Figure 13-1: Antiplatelet Action of Aspirin (Modified After Taneja et.al 2004) ASPIRIN RESISTANCE

Figure 13-1: Antiplatelet Action of Aspirin (Modified After Taneja et.al 2004) ASPIRIN RESISTANCE CHAPTER 13 ASPIRIN Action Aspirin Resistance Aspirin Dose Therapeutic Efficacy - Secondary prevention - Acute coronary syndromes - Primary prevention Limitations and Side Effects Aspirin Aspirin should

More information

Cell-Derived Inflammatory Mediators

Cell-Derived Inflammatory Mediators Cell-Derived Inflammatory Mediators Introduction about chemical mediators in inflammation Mediators may be Cellular mediators cell-produced or cell-secreted derived from circulating inactive precursors,

More information

10/17/16. Assessing cardiovascular risk through use of inflammation testing

10/17/16. Assessing cardiovascular risk through use of inflammation testing Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response

More information

Berries and Cardiovascular Health

Berries and Cardiovascular Health Berries and Cardiovascular Health Britt Burton-Freeman, PhD Institute for Food Safety and Health Illinois Institute of Technology bburton@iit.edu Berry Health Benefits Symposium Westlake Village CA, 2011

More information

Dyslipedemia New Guidelines

Dyslipedemia New Guidelines Dyslipedemia New Guidelines New ACC/AHA Prevention Guidelines on Blood Cholesterol November 12, 2013 Mohammed M Abd El Ghany Professor of Cardiology Cairo Universlty 1 1 0 Cholesterol Management Pharmacotherapy

More information

Welcome! Mark May 14, Sat!

Welcome! Mark May 14, Sat! Welcome! Mark May 14, Sat! Do We Have All Answers with Statins In Treating Patients with Hyperlipidemia? Kwang Kon Koh, MD, PhD, FACC, FAHA Cardiology, Gil Heart Center, Gachon Medical School, Incheon,

More information

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2 Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III

More information

Obesity is related to a higher inflammatory responsive state of circulating cells after stimulation of toll like receptor 2 and 4.

Obesity is related to a higher inflammatory responsive state of circulating cells after stimulation of toll like receptor 2 and 4. Toll Like Receptor Response and traditional risk factors for atherosclerosis: Obesity is related to a higher inflammatory responsive state of circulating cells after stimulation of toll like receptor 2

More information

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health

More information

Blood Vessel Mechanics

Blood Vessel Mechanics Blood Vessel Mechanics Ying Zheng, Ph.D. Department of Bioengineering BIOEN 326 11/01/2013 Blood Vessel Structure A Typical Artery and a Typical Vein Pressure and Blood Flow Wall stress ~ pressure Poiseuille

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

Obesity mediated hypertension and renal dysfunction

Obesity mediated hypertension and renal dysfunction Obesity mediated hypertension and renal dysfunction Gergely Bodor Marion Hervouet Nicky Honnef Mariarosaria Malgadi Julie Robert Tutor: Pr Alina Parvu Objectives 1. Introduction 2. Renal structural and

More information

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools. UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,

More information

PCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure

PCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure PCTH 400 LAST LECTURE Endothelial dysfunction and cardiovascular diseases. Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure Blood pressure

More information

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t? Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

PCSK9 Inhibitors and Modulators

PCSK9 Inhibitors and Modulators PCSK9 Inhibitors and Modulators Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Disclosures Speaker s

More information

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Long-Term Complications of Diabetes Mellitus Macrovascular Complication Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

http://noodlemaz.wordpress.com/category/science/cancer/ Outline Introduction Serious nature of Cardiovascular Disease (CVD) How to prevent CVD? The disease process Damage and plaque development Current

More information

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the limbs and major organs. A range of important pathologies

More information

C-reactive protein. ; Friend or Foe? Ki Hoon Han MD PhD Asan Medical Center Seoul, Korea

C-reactive protein. ; Friend or Foe? Ki Hoon Han MD PhD Asan Medical Center Seoul, Korea C-reactive protein ; Friend or Foe? Ki Hoon Han MD PhD Asan Medical Center Seoul, Korea I. Inflammation and atherogenesis Atherosclerosis is an inflammatory disease Recruitment of Blood Monocytes by Endothelial

More information

SYNDROME IN WOMEN IN PERIMINOPAUSE

SYNDROME IN WOMEN IN PERIMINOPAUSE УДК 257.36 Kodirova G.I., Kholikova D.S., Toshtemirova I.M. Andijan State Medical Institute Uzbekistan, Andijan сity Кодирова Г.И., Холикова Д.С., Тоштемирова И.М. Андижанский государственный медицинский

More information

PATIENTS AND METHODS:

PATIENTS AND METHODS: BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Sarah Alexander, MD Assistant Professor of Medicine Division of Cardiology Rush University Medical Center 2/8/2017 Rush is a not-for-profit health care, education and research

More information

Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode Island Cardiology Center

Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode Island Cardiology Center Primary and Secondary Prevention of Coronary Artery Disease: What is the role of non statin drugs (fenofibrates, fish oil, niacin, folate and vitamins)? Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode

More information

Annals of RSCB Vol. XVI, Issue 1

Annals of RSCB Vol. XVI, Issue 1 THE STUDY OF PROTHROBOTIC STATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASES Oana Bădulescu 1, Codruţa Bădescu 2, Manuela Ciocoiu 1, Magda Bădescu 1 1 DEPARTMENT OF PATHOPHYSIOLOGY;

More information

Statins and endothelium function

Statins and endothelium function Statins and endothelium function Matthias Endres Berlin, Germany Klinik und Poliklinik für Neurologie Conflict of interest: research grant from AstraZeneca from prevention to acute therapy... Pleiotropic

More information

THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ

THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ Disclosures: On National Advisory Boards of: (1) Pfizer Pharmaceuticals (2) MSD (3) Roche Pharmaceuticals (4) Abbott International: AfME Rheumatology

More information

Inflammation in heart failure: biomarker, bystander or mediator

Inflammation in heart failure: biomarker, bystander or mediator Inflammation in heart failure: biomarker, bystander or mediator Novel matricellular proteins to target Javier Díez, MD, PhD. Centre of Applied Medical Research and University Clinic School of Medicine,

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015 Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have

More information

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber ATHEROSCLEROSIS زيد ثامر جابر Zaid. Th. Jaber Objectives 1- Review the normal histological features of blood vessels walls. 2-define the atherosclerosis. 3- display the risk factors of atherosclerosis.

More information

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,

More information

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010 Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010 Content Introduction The number 1 killer in America Some statistics

More information

The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research

The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research I. Basic Physiology of Circulation A. The Vascular Endothelium The endothelium is a complex

More information

2/10/2014. The Vascular Biology of Eating. Robert A. Vogel, MD Clinical Professor of Medicine University of Colorado Denver

2/10/2014. The Vascular Biology of Eating. Robert A. Vogel, MD Clinical Professor of Medicine University of Colorado Denver //4 The Vascular Biology of Eating Robert A. Vogel, MD Clinical Professor of Medicine University of Colorado Denver Disclosure: Consultant Pritikin Longevity Center Histological and Vascular Biological

More information

Metabolic syndrome, obesity, diabetes, and theier implications

Metabolic syndrome, obesity, diabetes, and theier implications Metabolic syndrome, obesity, diabetes, and theier implications jan.krtil@lf1.cuni.cz Institute of Medical Biochemistry and Laboratory Diagnostics &1 st Department of Medicine Diabetes mellitus type 2 (T2DM)

More information

Innate Immunity in Atherosclerosis

Innate Immunity in Atherosclerosis Innate Immunity in Atherosclerosis Peter Libby Brigham & Women s Hospital Harvard Medical School IAS Amsterdam May 26, 2015 ACS Stable demand angina Characteristics of Atherosclerotic Plaques Associated

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital

More information

DECLARATION OF CONFLICT OF INTEREST. No disclosures

DECLARATION OF CONFLICT OF INTEREST. No disclosures DECLARATION OF CONFLICT OF INTEREST No disclosures micrornas: Role in progression of atherosclerosis Christian Weber Institute for Cardiovascular Prevention (IPEK) Ludwig-Maximilians-University Munich

More information

Quinn Capers, IV, MD

Quinn Capers, IV, MD Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular

More information

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids: CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation

More information

Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications

Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications 12 th Annual Cardiovascular Disease Prevention Symposium February 8, 2013 KEYNOTE ADDRESS Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications Ira Tabas, M.D., Ph.D. Richard J.

More information